NCT03657550 is a Phase 1 clinical trial of Levamlodipine, Amlodipine in Hypertension, sponsored by Conjupro Biotherapeutics, Inc..

Who is sponsoring NCT03657550?

NCT03657550 is sponsored by Conjupro Biotherapeutics, Inc..

What drugs are being tested in NCT03657550?

Interventions in NCT03657550: Levamlodipine, Amlodipine, Amlodipine, Levamlodipine.

What condition does NCT03657550 study?

NCT03657550 studies Hypertension.

Is NCT03657550 still recruiting?

NCT03657550 is currently completed. Last updated 16 September 2021.

Last reviewed 2021-09-16 · How we verify

NCT03657550

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Bioavailability of 5 mg of Levamlodipine Maleate Tablets Versus 10 mg of Amlodipine Besylate Tablet in Healthy Subjects

Completed Phase 1 Last updated 16 September 2021

What this trial tests

Phase 1 trial testing Levamlodipine, Amlodipine in Hypertension in 36 participants. Completed in 6 September 2018.

Timeline

31 May 2018

Primary endpoint
6 September 2018

6 September 2018

Quick facts

Lead sponsor	Conjupro Biotherapeutics, Inc.
Phase	Phase 1
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	sequential
Masking	none
Primary purpose	treatment
Enrollment	36
Start date	31 May 2018
Primary completion	6 September 2018
Estimated completion	6 September 2018
Sites	1 location across United States

Drugs / interventions tested

Levamlodipine, Amlodipine — full drug profile →
Amlodipine, Levamlodipine — full drug profile →

Conditions studied

Hypertension — all drugs for Hypertension →

Sponsor

Conjupro Biotherapeutics, Inc. — full company profile →

Who can join

Adults 18 to 45, any sex, with Hypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study are (1) to assess the relative bioavailability (BA) of a single oral dose of either 5 mg of Levamlodipine Maleate Tablets from CSPC or 10 mg of Amlodipine Besylate Tablet (NORVASC®) from Pfizer Inc. under fasting condition in male and female healthy subjects; and (2) to evaluate food effect on the PK profile of Levamlodipine Maleate Tablets from CSPC.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hypertension

Currently open trials in the same condition.

NCT07413159 — The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans A · NA · recruiting
NCT07361276 — Observational Study That Will Evaluate Treatment Patterns in the Management of Hypertension in the Public Primary Care S · recruiting
NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
NCT07238400 — Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia · Phase 2 · recruiting
NCT07135505 — Early Time-Restricted Eating in Older Adults With Hypertension · NA · recruiting

Other Conjupro Biotherapeutics, Inc. trials

Trials by the same sponsor.

NCT04675450 — NBP in Women With Metastatic Breast Cancer to Prevent Nab-paclitaxel Induced Toxic Neuropathy · Phase 2 · withdrawn
NCT05043987 — Dose Escalation and Expansion Study of CPO102, an Anti-claudin 18.2 ADC in Patients With Advanced Cancers · Phase 1 · withdrawn
NCT04853329 — Dose Escalation and Expansion Study of CPO107 for Patients With Advanced CD20-positive Non-Hodgkins Lymphoma · Phase 1 · terminated
NCT03567694 — Single and Multiple Doses of HA115 and Food Effect in Healthy Adult Volunteers · Phase 1 · withdrawn
NCT04931823 — Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors · Phase 1 · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03657550 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Conjupro Biotherapeutics, Inc.
Last refreshed: 16 September 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03657550.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing